Literature DB >> 20585062

Cholesterol-lowering therapy for primary prevention: still much we don't know.

Lee A Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20585062     DOI： 10.1001/archinternmed.2010.168

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  5 in total

1.  Facts and ideas from anywhere.

Authors:  William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-01

2.  Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk.

Authors:  Jon Conly; Fiona Clement; Marcello Tonelli; Brenda Hemmelgarn; Scott Klarenbach; Anita Lloyd; Finlay A McAlister; Don Husereau; Natasha Wiebe; Flora Au; Braden Manns
Journal:  CMAJ       Date:  2011-10-11       Impact factor: 8.262

Review 3.  Are cardiovascular benefits in statin lipid effects dependent on baseline lipid levels?

Authors:  Keith C Ferdinand
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

Review 4.  Problems and possible solutions for therapy with statins.

Authors:  Thomas F Whayne
Journal:  Int J Angiol       Date:  2013-06

5.  Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?

Authors:  Michel de Lorgeril; Patricia Salen; Pascal Defaye; Mikael Rabaeus
Journal:  BMC Med       Date:  2013-01-04       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.